TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 260nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 490nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 580nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 650nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 980nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: <1.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: <1.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: <1.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 1.10E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 1.10E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 1.30E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 1.60E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 4.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 4.30E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 5.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 5.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 7.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 7.00E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: 8.80E+3nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >1.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
The Board Of Trustees Of The Leland Stanford Junion University
US Patent
Affinity DataIC50: >3.00E+4nMAssay Description:Drugs belonging to different classes have been shown to be associated with QT prolongation and in some cases serious ventricular arrhythmias. The mos...More data for this Ligand-Target Pair